Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19961 | 418 | 27.7 | 53% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | AMISULPRIDE | Author keyword | 50 | 38% | 25% | 105 |
| 2 | LEVOSULPIRIDE | Author keyword | 8 | 48% | 3% | 12 |
| 3 | MEBEVERINE | Author keyword | 7 | 48% | 3% | 11 |
| 4 | MEBEVERINE HYDROCHLORIDE | Author keyword | 5 | 43% | 2% | 9 |
| 5 | SULTOPRIDE | Author keyword | 1 | 33% | 1% | 3 |
| 6 | TIAPRIDE | Author keyword | 1 | 15% | 2% | 7 |
| 7 | 2 COMPARTMENT | Author keyword | 1 | 50% | 0% | 1 |
| 8 | ABT SOZIALPSYCHIAT PSYCHOTHER | Address | 1 | 50% | 0% | 1 |
| 9 | ALIZARINS | Author keyword | 1 | 50% | 0% | 1 |
| 10 | ANTIPSYCHOTIC ANIMAL MODELS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | AMISULPRIDE | 50 | 38% | 25% | 105 | Search AMISULPRIDE | Search AMISULPRIDE |
| 2 | LEVOSULPIRIDE | 8 | 48% | 3% | 12 | Search LEVOSULPIRIDE | Search LEVOSULPIRIDE |
| 3 | MEBEVERINE | 7 | 48% | 3% | 11 | Search MEBEVERINE | Search MEBEVERINE |
| 4 | MEBEVERINE HYDROCHLORIDE | 5 | 43% | 2% | 9 | Search MEBEVERINE+HYDROCHLORIDE | Search MEBEVERINE+HYDROCHLORIDE |
| 5 | SULTOPRIDE | 1 | 33% | 1% | 3 | Search SULTOPRIDE | Search SULTOPRIDE |
| 6 | TIAPRIDE | 1 | 15% | 2% | 7 | Search TIAPRIDE | Search TIAPRIDE |
| 7 | 2 COMPARTMENT | 1 | 50% | 0% | 1 | Search 2+COMPARTMENT | Search 2+COMPARTMENT |
| 8 | ALIZARINS | 1 | 50% | 0% | 1 | Search ALIZARINS | Search ALIZARINS |
| 9 | ANTIPSYCHOTIC ANIMAL MODELS | 1 | 50% | 0% | 1 | Search ANTIPSYCHOTIC+ANIMAL+MODELS | Search ANTIPSYCHOTIC+ANIMAL+MODELS |
| 10 | D 2 3 RECEPTOR OCCUPANCY | 1 | 50% | 0% | 1 | Search D+2+3+RECEPTOR+OCCUPANCY | Search D+2+3+RECEPTOR+OCCUPANCY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LIMBIC SELECTIVITY | 28 | 50% | 10% | 40 |
| 2 | SULTOPRIDE | 23 | 100% | 2% | 10 |
| 3 | MEDIUM TERM TREATMENT | 9 | 83% | 1% | 5 |
| 4 | VS RISPERIDONE | 5 | 55% | 1% | 6 |
| 5 | SULPIRIDE | 4 | 16% | 6% | 25 |
| 6 | DEFICIT SYMPTOMS | 4 | 67% | 1% | 4 |
| 7 | MEBEVERINE HYDROCHLORIDE | 4 | 67% | 1% | 4 |
| 8 | D 2 D 3 RECEPTOR ANTAGONIST | 3 | 60% | 1% | 3 |
| 9 | LEVOSULPIRIDE | 2 | 36% | 1% | 4 |
| 10 | CYCLODEXTRIN ADDITIVES | 1 | 38% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Amisulpride - A review of its use in the management of schizophrenia | 2004 | 52 | 52 | 63% |
| A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers | 2002 | 64 | 24 | 42% |
| Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality | 2003 | 42 | 66 | 32% |
| Practical issues with amisulpride in the management of patients with schizophrenia | 2008 | 14 | 56 | 38% |
| Amisulpride - A review of its use in the management of schizophrenia | 2001 | 40 | 78 | 40% |
| A risk-benefit assessment of sulpiride in the treatment of schizophrenia | 1996 | 34 | 37 | 49% |
| Amisulpride - A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of schizophrenia | 1996 | 59 | 39 | 23% |
| Social functioning and quality of life in the schizophrenic patient: advantages of amisulpride | 2002 | 24 | 32 | 38% |
| Possibilities in using sulpiride in the treatment of psychotic disorders | 2012 | 0 | 24 | 38% |
| SULPIRIDE - AN ANTIPSYCHOTIC WITH SELECTIVE DOPAMINERGIC ANTAGONIST PROPERTIES | 1995 | 46 | 34 | 35% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ABT SOZIALPSYCHIAT PSYCHOTHER | 1 | 50% | 0.2% | 1 |
| 2 | CLIN MBC 03 65 | 1 | 50% | 0.2% | 1 |
| 3 | INTERNAL MED CLIN DEV | 1 | 50% | 0.2% | 1 |
| 4 | BIOEQUIVALENCE BRIDGING STUDY | 1 | 13% | 1.0% | 4 |
| 5 | NEUROSCI SCARL | 0 | 33% | 0.2% | 1 |
| 6 | SCDU PSICOL CLIN ONCOL | 0 | 33% | 0.2% | 1 |
| 7 | CERCETARE DEZVOLTARE CHIM FARMACEUT | 0 | 25% | 0.2% | 1 |
| 8 | QUAL SECT | 0 | 25% | 0.2% | 1 |
| 9 | UMR 75 93 | 0 | 25% | 0.2% | 1 |
| 10 | KLIN PSYCHIAT PSYCHOTER IE | 0 | 20% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000216753 | REMOXIPRIDE//DA D2 RECEPTORS//DOPAMINE D 2 ANTAGONISTS |
| 2 | 0.0000162422 | SECT MOL ECOGENET//BROMOPRIDE//METOCLOPRAMIDE HYDROCHLORIDE |
| 3 | 0.0000125165 | CLOZAPINE//RISPERIDONE//OLANZAPINE |
| 4 | 0.0000077848 | COCHRANE IZOPHRENIA GRP//WARM SUPPLEMENTING KIDNEY YANG//SURG DEV SCI |
| 5 | 0.0000074111 | INO 2628 CZ//DOUBLE PEAKS//DISCONTINUOUS ABSORPTION |
| 6 | 0.0000066148 | NEGATIVE SYMPTOMS//DEFICIT SYNDROME//PANSS |
| 7 | 0.0000065031 | SERTINDOLE//PSYCHOPHARMACOL VENTURE//TROP TOXINOL UNIT |
| 8 | 0.0000064040 | ANTIPSYCHOTIC POLYPHARMACY//POLYPHARMACY//TUNKU ABDUL RAHMAN NEUROSCI |
| 9 | 0.0000061451 | SEXUAL DYSFUNCTION//HYPERPROLACTINEMIA//HYPERPROLACTINAEMIA |
| 10 | 0.0000059899 | PROD FORMULAT YODOGAWA KU//CHLORPHENESIN CARBAMATE//DISSOLUTION HEAT |